D. Yilmaz Et Al. , "The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.," Urology , vol.83, 2014
Yilmaz, D. Et Al. 2014. The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.. Urology , vol.83 .
Yilmaz, D., BAYATLI, N., UN, O., KADOWITZ, P., SIKKA, S., & GUR, S., (2014). The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.. Urology , vol.83.
Yilmaz, DİDEM Et Al. "The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.," Urology , vol.83, 2014
Yilmaz, DİDEM Y. Et Al. "The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.." Urology , vol.83, 2014
Yilmaz, D. Et Al. (2014) . "The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.." Urology , vol.83.
@article{article, author={DİDEM YILMAZ ORAL Et Al. }, title={The effect of intracavernosal avanafil, a newer phosphodiesterase-5 inhibitor, on neonatal type 2 diabetic rats with erectile dysfunction.}, journal={Urology}, year=2014}